Affimed and Roche ink $5bn plus cancer immunotherapy dealDeal is based on natural killer cell therapeutics Share XAffimed and Roche ink $5bn plus cancer immunotherapy dealhttps://pharmaphorum.com/news/affimed-and-roche-ink-5bn-plus-cancer-immunotherapy-deal/